Application of 50-gene breast cancer (BC) IMS and colorectal cancer (CRC) CMS classifiers to 90 prostate cancer (PC) cases reveals distinct subtypes

ImmunityBio, Inc.

© 2020 ImmunityBio, Inc. All rights reserved.

Privacy | Terms of Use.

© 2020 ImmunityBio, Inc. All rights reserved.

Privacy | Terms of Use.